Anticoagulation therapy / / edited by Ozcan Basaran, Murat Biteker.
The available parenteral and oral anticoagulants have a large clinical use. Understanding biochemistry of anticoagulants may help to improve therapeutic strategies. Resistance to vitamin K antagonist drugs might be a problem for rodent populations. Patients who have thrombogenic risk factors should...
Saved in:
| TeilnehmendeR: | |
|---|---|
| Place / Publishing House: | Rijeka, Croatia : : IntechOpen,, [2016] ©2016 |
| Year of Publication: | 2016 |
| Language: | English |
| Physical Description: | 1 online resource (140 pages) :; illustrations |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| id |
993545886104498 |
|---|---|
| ctrlnum |
(CKB)4970000000099157 (NjHacI)994970000000099157 (oapen)https://directory.doabooks.org/handle/20.500.12854/66919 (EXLCZ)994970000000099157 |
| collection |
bib_alma |
| record_format |
marc |
| spelling |
Basaran, Ozcan edt Anticoagulation therapy / edited by Ozcan Basaran, Murat Biteker. IntechOpen 2016 Rijeka, Croatia : IntechOpen, [2016] ©2016 1 online resource (140 pages) : illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier Open access Unrestricted online access star Description based on: online resource; title from PDF information screen (InTech, viewed October 17, 2022). The available parenteral and oral anticoagulants have a large clinical use. Understanding biochemistry of anticoagulants may help to improve therapeutic strategies. Resistance to vitamin K antagonist drugs might be a problem for rodent populations. Patients who have thrombogenic risk factors should be anticoagulated. The need for cardiac implantable electronic devices is increasing, and there is a substantial number of patients who are on oral anticoagulant therapy. Prothrombin complex concentrate and other plasma concentrates are useful to deal with over-coagulated situations. The efficacy and safety of non-vitamin K antagonist oral anticoagulants have been proven in large phase III trials. The real-world data suggest even better outcomes with these agents compared to vitamin K antagonists. English Anticoagulants (Medicine) Warfarin. Pharmacology 953-51-2666-0 Basaran, Ozcan, editor. Biteker, Murat, editor. |
| language |
English |
| format |
eBook |
| author2 |
Basaran, Ozcan, Biteker, Murat, |
| author_facet |
Basaran, Ozcan, Biteker, Murat, |
| author2_variant |
o b ob o b ob m b mb |
| author2_role |
TeilnehmendeR TeilnehmendeR |
| title |
Anticoagulation therapy / |
| spellingShingle |
Anticoagulation therapy / |
| title_full |
Anticoagulation therapy / edited by Ozcan Basaran, Murat Biteker. |
| title_fullStr |
Anticoagulation therapy / edited by Ozcan Basaran, Murat Biteker. |
| title_full_unstemmed |
Anticoagulation therapy / edited by Ozcan Basaran, Murat Biteker. |
| title_auth |
Anticoagulation therapy / |
| title_new |
Anticoagulation therapy / |
| title_sort |
anticoagulation therapy / |
| publisher |
IntechOpen IntechOpen, |
| publishDate |
2016 |
| physical |
1 online resource (140 pages) : illustrations |
| isbn |
953-51-7309-X 953-51-2667-9 953-51-2666-0 |
| callnumber-first |
R - Medicine |
| callnumber-subject |
RM - Therapeutics and Pharmacology |
| callnumber-label |
RM340 |
| callnumber-sort |
RM 3340 A585 42016 |
| illustrated |
Illustrated |
| dewey-hundreds |
600 - Technology |
| dewey-tens |
610 - Medicine & health |
| dewey-ones |
615 - Pharmacology & therapeutics |
| dewey-full |
615.718 |
| dewey-sort |
3615.718 |
| dewey-raw |
615.718 |
| dewey-search |
615.718 |
| work_keys_str_mv |
AT basaranozcan anticoagulationtherapy AT bitekermurat anticoagulationtherapy |
| status_str |
n |
| ids_txt_mv |
(CKB)4970000000099157 (NjHacI)994970000000099157 (oapen)https://directory.doabooks.org/handle/20.500.12854/66919 (EXLCZ)994970000000099157 |
| carrierType_str_mv |
cr |
| is_hierarchy_title |
Anticoagulation therapy / |
| author2_original_writing_str_mv |
noLinkedField noLinkedField |
| _version_ |
1789038456261836801 |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02218nam a2200433 i 4500</leader><controlfield tag="001">993545886104498</controlfield><controlfield tag="005">20240124175748.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr#|||||||||||</controlfield><controlfield tag="008">221017s2016 ci a o 000 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">953-51-7309-X</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">953-51-2667-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4970000000099157</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)994970000000099157</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/66919</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994970000000099157</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RM340</subfield><subfield code="b">.A585 2016</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">615.718</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Basaran, Ozcan</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Anticoagulation therapy /</subfield><subfield code="c">edited by Ozcan Basaran, Murat Biteker.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">IntechOpen</subfield><subfield code="c">2016</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Rijeka, Croatia :</subfield><subfield code="b">IntechOpen,</subfield><subfield code="c">[2016]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (140 pages) :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="506" ind1=" " ind2=" "><subfield code="a">Open access</subfield><subfield code="f">Unrestricted online access</subfield><subfield code="2">star</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on: online resource; title from PDF information screen (InTech, viewed October 17, 2022).</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The available parenteral and oral anticoagulants have a large clinical use. Understanding biochemistry of anticoagulants may help to improve therapeutic strategies. Resistance to vitamin K antagonist drugs might be a problem for rodent populations. Patients who have thrombogenic risk factors should be anticoagulated. The need for cardiac implantable electronic devices is increasing, and there is a substantial number of patients who are on oral anticoagulant therapy. Prothrombin complex concentrate and other plasma concentrates are useful to deal with over-coagulated situations. The efficacy and safety of non-vitamin K antagonist oral anticoagulants have been proven in large phase III trials. The real-world data suggest even better outcomes with these agents compared to vitamin K antagonists.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Anticoagulants (Medicine)</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Warfarin.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Pharmacology</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">953-51-2666-0</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Basaran, Ozcan,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Biteker, Murat,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2024-01-25 02:21:07 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2019-04-13 22:04:18 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338038320004498&Force_direct=true</subfield><subfield code="Z">5338038320004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338038320004498</subfield></datafield></record></collection> |